解读多药耐药性 Pseudomonas aeruginosa:机械洞察力和环境风险
Yang Pei1,2,3, Péter Hamar4, De-Sheng Pei1
1School of Public Health, Chongqing Medical University, Chongqing 400016, China.
Toxics
|April 25, 2025
概括
耐多药性Pseudomonas aeruginosa (MDR P. aeruginosa) 构成临床和环境威胁. 本综述探讨了耐药性机制,检测和新疗法,强调了抗菌素耐药性的综合解决方案.
科学领域:
- 微生物学 微生物学
- 遗传学 是一个遗传学.
- 环境科学 环境科学
背景情况:
- 抗多药性 (MDR) *Pseudomonas aeruginosa* (*P. aeruginosa*) 是一个日益严重的临床和环境问题.
- 了解MDR发展的机制对于有效的治疗和控制至关重要.
研究的目的:
- 审查P. aeruginosa*中MDR发展的机制.
- 评估当前和新兴的检测和治疗策略.
- 为了突出MDR *P. aeruginosa*的环境风险和适应能力.
主要方法:
- 对遗传突变,水平基因转移 (HGT) 和毒性因素的文献综述.
- 评估传统和分子诊断技术.
- 对现有和新型治疗干预措施的分析,包括基因编辑技术.
主要成果:
- MDR的发展涉及遗传突变,HGT和基因-病毒性因子相互作用.
- 快速和准确的诊断是必不可少的.
- 像RNA干扰和CRISPR-Cas9这样的创新疗法非常有前途.
- MDR *P. aeruginosa* 具有显著的环境分布和适应能力.
结论:
- 需要一种综合的方法,将基因组学,临床实践和环境监测结合起来.
- 持续的研究和开发对于打击抗菌素耐药性至关重要.
- 保持抗生素有效性需要针对MDR*P. aeruginosa*的多方面的策略.
更多相关视频
10:43Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein
Published on: December 3, 2010
21.3K
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
10.5K
相关概念视频
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Carrier-Mediated Transport
212
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
212
